APA (7th ed.) Citation

Bakouny, Z., Grover, P., Labaki, C., Awosika, J., Gulati, S., Hsu, C., . . . Wise-Draper, T. (2022). 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer. Annals of Oncology, 33, S772. https://doi.org/10.1016/j.annonc.2022.07.630

Chicago Style (17th ed.) Citation

Bakouny, Z., et al. "502P Association of Immunotherapy and Immunosuppression with Severe COVID-19 Disease in Patients with Cancer." Annals of Oncology 33 (2022): S772. https://doi.org/10.1016/j.annonc.2022.07.630.

MLA (9th ed.) Citation

Bakouny, Z., et al. "502P Association of Immunotherapy and Immunosuppression with Severe COVID-19 Disease in Patients with Cancer." Annals of Oncology, vol. 33, 2022, p. S772, https://doi.org/10.1016/j.annonc.2022.07.630.